These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31714050)

  • 1. A Dual-Targeting Functionalized Graphene Film for Rapid and Highly Sensitive Fluorescence Imaging Detection of Hepatocellular Carcinoma Circulating Tumor Cells.
    Wu C; Li P; Fan N; Han J; Zhang W; Zhang W; Tang B
    ACS Appl Mater Interfaces; 2019 Dec; 11(48):44999-45006. PubMed ID: 31714050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
    Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Xia W; Li H; Li Y; Li M; Fan J; Sun W; Li N; Li R; Shao K; Peng X
    Nano Lett; 2021 Jan; 21(1):634-641. PubMed ID: 33264027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
    Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
    BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
    Kelley RK; Magbanua MJ; Butler TM; Collisson EA; Hwang J; Sidiropoulos N; Evason K; McWhirter RM; Hameed B; Wayne EM; Yao FY; Venook AP; Park JW
    BMC Cancer; 2015 Mar; 15():206. PubMed ID: 25884197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
    Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
    World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay.
    Zhang Y; Zhang X; Zhang J; Sun B; Zheng L; Li J; Liu S; Sui G; Yin Z
    Cancer Biol Ther; 2016 Nov; 17(11):1177-1187. PubMed ID: 27662377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glutathione activatable bioprobe for detection of hepatocellular carcinoma cells in peripheral blood via carbohydrate-protein interaction.
    Wang Y; Li J; Pei Z; Pei Y
    Anal Chim Acta; 2022 Aug; 1221():340106. PubMed ID: 35934396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratin.
    Li J; Chen L; Zhang X; Zhang Y; Liu H; Sun B; Zhao L; Ge N; Qian H; Yang Y; Wu M; Yin Z
    PLoS One; 2014; 9(4):e96185. PubMed ID: 24763545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-Selective and Dual-Enhanced SERS Nanoprobes Strategy for Circulating Hepatocellular Carcinoma Cells Detection.
    Pang Y; Wang C; Xiao R; Sun Z
    Chemistry; 2018 May; 24(27):7060-7067. PubMed ID: 29521467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.
    Li YM; Xu SC; Li J; Han KQ; Pi HF; Zheng L; Zuo GH; Huang XB; Li HY; Zhao HZ; Yu ZP; Zhou Z; Liang P
    Cell Death Dis; 2013 Oct; 4(10):e831. PubMed ID: 24091674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycoplasma infection promotes tumor progression via interaction of the mycoplasmal protein p37 and epithelial cell adhesion molecule in hepatocellular carcinoma.
    Kim MK; Shin SJ; Lee HM; Choi HS; Jeong J; Kim H; Paik SS; Kim M; Choi D; Ryu CJ
    Cancer Lett; 2019 Jul; 454():44-52. PubMed ID: 30980864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy.
    Jia M; Mao Y; Wu C; Wang S; Zhang H
    Anal Chim Acta; 2019 Nov; 1082():136-145. PubMed ID: 31472702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry.
    Mu H; Lin KX; Zhao H; Xing S; Li C; Liu F; Lu HZ; Zhang Z; Sun YL; Yan XY; Cai JQ; Zhao XH
    World J Gastroenterol; 2014 May; 20(19):5826-38. PubMed ID: 24914343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy.
    Xu W; Cao L; Chen L; Li J; Zhang XF; Qian HH; Kang XY; Zhang Y; Liao J; Shi LH; Yang YF; Wu MC; Yin ZF
    Clin Cancer Res; 2011 Jun; 17(11):3783-93. PubMed ID: 21527564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer.
    Nam SJ; Yeo HY; Chang HJ; Kim BH; Hong EK; Park JW
    Cancer Res Treat; 2016 Oct; 48(4):1229-1242. PubMed ID: 27034142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.
    Qi LN; Xiang BD; Wu FX; Ye JZ; Zhong JH; Wang YY; Chen YY; Chen ZS; Ma L; Chen J; Gong WF; Han ZG; Lu Y; Shang JJ; Li LQ
    Cancer Res; 2018 Aug; 78(16):4731-4744. PubMed ID: 29915159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma.
    Takahashi K; Ofuji K; Hiramatsu K; Nosaka T; Naito T; Matsuda H; Endo K; Higuchi M; Ohtani M; Nemoto T; Nakamoto Y
    Cancer Med; 2021 Apr; 10(7):2300-2309. PubMed ID: 33675149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterior Approach to Improve the Prognosis in HCC Patients Via Decreasing Dissemination of EpCAM
    Hao S; Chen S; Tu C; Huang T
    J Gastrointest Surg; 2017 Jul; 21(7):1112-1120. PubMed ID: 28378318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.